The global demand for Glucose Biosensors Market is presumed to reach the market size of nearly USD 22.28 MN by 2028 from USD 11.42 MN in 2021 with a CAGR of 10.02% under the study period 2022 - 2028.
Glucose biosensors are an important part of glucose monitoring systems that help in monitoring blood glucose levels in diabetic patients and are an essential part of diabetes management. Glucose biosensors are now available as small and minimally invasive devices that measure glucose levels, even in outpatient settings and home care. Glucose biosensors can be used in home and outpatient settings to measure glucose levels. Glucose biosensors that can be calibrated and use different body fluids such as sweat, blood, saliva, and tears are being researched more and more.
Market Dynamics
The rising incidence of diabetes worldwide is one of the most notable factors for the glucose biosensors market's growth and development. Moreover, the senior population is more prone to disorders such as diabetes, which may increase the demand for glucose biosensor devices. Further, the constant technological advancements that give rise to an increased number of innovative and minimally invasive products are anticipated to fuel the global glucose biosensors market soon. In addition, rising cases of hyperglycemic disorders and increased emphasis on regular diabetes check-ups drive revenue growth in this segment. Another major driver of the global glucose biosensors market's growth and expansion is the rising demand for self-monitoring devices. However, the strict regulatory framework and the high price of glucose biosensors are expected to limit the market growth.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of glucose biosensors. The growth and trends of glucose biosensors industry provide a holistic approach to this study.
Market Segmentation
This section of the glucose biosensors market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- CGM (Continuous Glucose Monitoring)
- SMBG (Self-Monitoring Blood Glucose)
By Technology
- Electrochemical Biosensors
- Optical Biosensors
By End Users
- Hospitals
- Home Care
- Diagnostic Centres & Clinics
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Glucose Biosensors market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Glucose Biosensors Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the glucose biosensors market include Ascensia Diabetes Care Holdings AG. (Senseonics, Inc.), Abbott, Lifescan Inc., Universal Biosensors, Nova Biomedical, Med Trust, Taidoc Technology Corporation, Roche AG., Dexcom, Trividia Health, Pinnacle Technology, Medtronic, i-SENS Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
